Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EASTMAN CHEMICAL COEMN · Entity 1780 | SVP, Chf Mfg & Eng Ofc | February 25, 2022 | March 01, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EASTMAN CHEMICAL CO
Report date February 25, 2022 · Filed March 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,664 |
Ending reported balance
After 2022-02-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-02-25 · Sale · Disposed 4,858 · Balance 3,509 F1: Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $120.59 to $121.00. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Row 2 · 2022-02-28 · Gift · Disposed 845 · Balance 2,664 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $120.80 · Expires 2032-02-24 | Direct | 10,378 |
Reported balance
After 2022-02-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-25 · Grant · Acquired 10,378 · Balance 10,378 F2: One-third of the option becomes exercisable on February 25, 2023, February 25, 2024, and February 25, 2025, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $120.59 to $121.00. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
F2: One-third of the option becomes exercisable on February 25, 2023, February 25, 2024, and February 25, 2025, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2017 Filed Aug 7, 2017 18:58 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 1,400 | $84.24 | $117,936.00 |
DisclosureSEC source: 0000899243-17-019810 · doc4.xml · nonDerivative · entry 2 COX MARK K · CIK 0001595866 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,014 F1 · balance_after: Includes 74 shares acquired since February 17, 2017 resulting from automatic reinvestment of dividends. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 18:58 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 1,400 | $38.30 | $53,620.00 |
DisclosureSEC source: 0000899243-17-019810 · doc4.xml · nonDerivative · entry 1 COX MARK K · CIK 0001595866 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 74 shares acquired since February 17, 2017 resulting from automatic reinvestment of dividends. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 14:40 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 15,074 | $0.00 Strike: $80.25 | $0.00 |
DisclosureSEC source: 0000899243-17-005934 · doc4.xml · derivative · entry 1 COX MARK K · CIK 0001595866 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,074 Underlying: Common Stock · 15,074 shares Expires 2027-02-27 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 28, 2018, February 28, 2019, and February 28, 2020, respectively. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 13:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 341 | $80.25 | $27,365.25 |
DisclosureSEC source: 0000899243-17-004641 · doc4.xml · nonDerivative · entry 2 COX MARK K · CIK 0001595866 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,940 F3 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 13:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-004641 · doc4.xml · nonDerivative · entry 1 COX MARK K · CIK 0001595866 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,281 F1 · shares: Payout under performance shares awarded at beginning of three-year (2014-2016) performance period. F2 · balance_after: Includes 136 shares acquired since February 19, 2016 resulting from automatic reinvestment of dividends. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 19:39 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | OtherPhantom Stock Units · Derivative | 4,108 | $78.45 Strike: $0.00 | $322,272.60 |
DisclosureSEC source: 0000899243-17-002922 · doc4.xml · derivative · entry 2 COX MARK K · CIK 0001595866 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,108 shares Expires not disclosed F2 · derivative.exercise_price: Phantom stock units credited under the Executive Deferred Compensation Plan (the "EDCP"), each having a value equal to the market value of one share of common stock and payable only in cash and, subject to certain acceleration and early withdrawal provisions, after termination of employment. F3 · shares: Includes 39 phantom stock units credited under the Executive Defferred Compensation Plan since July 1, 2016 as a result of hypothetical reinvestment of dividend equivalents. F2 · derivative.exercise_date: Phantom stock units credited under the Executive Deferred Compensation Plan (the "EDCP"), each having a value equal to the market value of one share of common stock and payable only in cash and, subject to certain acceleration and early withdrawal provisions, after termination of employment. F2 · derivative.expiration_date: Phantom stock units credited under the Executive Deferred Compensation Plan (the "EDCP"), each having a value equal to the market value of one share of common stock and payable only in cash and, subject to certain acceleration and early withdrawal provisions, after termination of employment. F3 · derivative.underlying_shares: Includes 39 phantom stock units credited under the Executive Defferred Compensation Plan since July 1, 2016 as a result of hypothetical reinvestment of dividend equivalents. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 19:39 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | OtherCommon Stock | 416 | $78.45 | $32,635.20 |
DisclosureSEC source: 0000899243-17-002922 · doc4.xml · nonDerivative · entry 1 COX MARK K · CIK 0001595866 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · shares: Includes 8 shares acquired since February 19, 2016 resulting from automatic reinvestment of dividends. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.